List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Transradial Access Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 112 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 112 pages
- Published: 07-06-2019
Market Overview
The Transradial Access Devices Market is growing because of increasing preference for interventional procedures using radial artery access, the growing prevalence of cardiovascular diseases and increasing use of radial access devices in pediatric patients.
There are various applications of transradial access procedure. It is used in the diagnosis of coronary artery diseases including diagnostic angiography, angioplasty, and percutaneous stenting. When a person suffers from chest pain, this procedure can determine the blockage in heart arteries. Furthermore, it also helps healthcare providers to determine a treatment plan. This test is called coronary angiography. If a patient has a known blockage in a coronary artery, cardiac catheterization can be administered using a technique called coronary angioplasty. A balloon is attached to the tip of the catheter. When the balloon is in place, it is inflated and presses the plaque to the side of the blood vessel, increasing blood flow through the artery.
It was found that transradial access reduces the risk of bleeding by over 70 percent even among high-risk group. All the various applications and advantages of the transradial access procedures are believed to fuel the growth of the market.
Scope of the Report
As per the scope of the report, Transradial access is required for a catherization procedure performed for the diagnosis and treatment of arterial diseases such as peripheral artery disease and coronary artery disease, among others.
Key Market Trends
Drug Administration is Expected to be the Fastest Growing Sub-Segment in the Application
The drug administration segment of the transradial access market is believed to grow faster during the forecast period. This is majorly due to the growing usage of vascular access devices over other devices especially for the treatment of infectious diseases and some of the life-threatening diseases such as Cancer. In addition, The rising prevalence of chronic diseases across the globe is another factor augmenting the growth of this segment.
North America Dominates the Market and is Expected to Follow the Same Trend for Few More Years
The North American market is likely to grow with the highest growth rate, owing to factors such as the growing prevalence of CVDs, a rising number of conferences and workshops, the large number of cancer patients, and increase in research and clinical trials for vascular access devices. APAC is also expected to show a substantial increase in CAGR since there is a huge population suffering from cardiovascular diseases.
Competitive Landscape
The transradial access market is competitive and is inclusive of the big players along with some of the local players in the market. Some of the key players of the market include Becton, Dickinson and Company, Boston Scientific Corporation, Edward Lifesciences Corporation, Medtronic plc, and Terumo Corporation.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Preference for Interventional Procedures Using Radial Artery Access
4.2.2 Growing Prevalence of Cardiovascular Diseases Due to Lifestyle Related Diseases
4.2.3 Growing Use of Radial Access Devices in Pediatric Patients
4.3 Market Restraints
4.3.1 High Costs Involved in the Placement and Maintenance of Vascular Access Devices
4.3.2 Lack of Trained Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Catheters
5.1.2 Guidewires
5.1.3 Sheaths and Sheath Introducers
5.1.4 Accessories
5.2 By Application
5.2.1 Drug Administration
5.2.2 Fluid and Nutrition Administration
5.2.3 Blood Transfusion
5.2.4 Diagnostics and Testing
5.3 By End User
5.3.1 Hospitals
5.3.2 Clinics and Ambulatory Care Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Ameco Medical
6.1.2 Angiodynamics, Inc.
6.1.3 Becton, Dickinson and Company
6.1.4 Boston Scientific Corporation
6.1.5 Edward Lifesciences Corporation
6.1.6 Medtronic plc
6.1.7 Merit Medical Systems
6.1.8 Nipro Medical Corporation
6.1.9 Oscor Inc
6.1.10 Smiths Medical
6.1.11 Teleflex Incorporated
6.1.12 Terumo Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Catheters
Guidewires
Sheaths and Sheath Introducers
Accessories
By Application
Drug Administration
Fluid and Nutrition Administration
Blood Transfusion
Diagnostics and Testing
By End User
Hospitals
Clinics and Ambulatory Care Centers
Others
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Antidepressant Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 112 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 112 pages
- Published: 07-06-2019
Market Overview
The major factors for the growth of the global antidepressant market include the rising cases of depression, increasing awareness about depression, and the emergence of novel biologics.
Globally, more than 300 million people across all age groups suffer from depression, and this number is rising at a fast pace. The increase in the number of young adults affected by some form of depression is as high as 8%. Depression due to factors, such as social isolation and stressful work environment has contributed the most toward increasing the number of people suffering from depression. The number of people falling prey to depression and related disorders is expected to continue to increase, as a result of improper eating habits, stressful work schedule, increasing isolation from family and loved ones due to technology, and the inability to adapt to the rapid pace, at which, the world is moving forward. In countries, such as the United Kingdom and the United States, which are characterized by their fast-paced economies, the percentage of ‘affected population’ in every age group is quite high. In addition, increasing aged population across the world enhances the potential of the market studied over the forecast period. According to the estimates of WHO, in 2015, 322 million people were suffering from depression, globally, and nearly half the number of these people belong to the Southeast Asian region and the Western Pacific region. Thus, the rising cases of depression across the world are expected to drive the overall growth of the market studied over the forecast period.
Scope of the Report
As per the scope of the report, antidepressant drugs are used for the treatment of major depressive disorders and other conditions, including dysthymia, anxiety disorders, obsessive-compulsive disorder (OCD), eating disorders, chronic pain, neuropathic pain, etc. The market is segmented by type of product, depressive disorder, and geography.
Key Market Trends
Major Depressive Disorder Segment by Depressive Disorder is Expected to Account for the Largest Market Share During the Forecast Period
The major depressive disorder possible causes comprise of the combination of biological, psychological, and social sources of distress. The major risk factors include family history, significant life changes, certain medications, chronic health problems, and substance abuse. As per the data published by the National Institute of Mental Health, an estimated 16.2 million adults in the United States had at least one major depressive episode. This number represented 6.7% of all US adults and is majorly prevalent in women as compared to men. Most commonly, selective serotonin reuptake inhibitors (SSRI) are used in the treatment of major depression, while there are some therapies available to normalize brain changes associated with depression. Thus, owing to the rising number of the patient pool, the market is expected to witness high growth over the forecast period.
North America accounted for the Largest Share in the Global Market
The increasing cases of depression is one of the major factors that is expected to drive the overall growth of the US antidepressant market over the forecast period. Moreover, there is a rise in the geriatric population in the United States, which is expected to create more opportunities for market players in the region. Women are twice as likely to be affected by generalized anxiety disorder (GAD) when compared to men. Six million adults, or 2.7% of the US population suffer from panic disorders, and around 2.2 million or 1.0% of the US population suffer from obsessive-compulsive disorder (OCD), which is found to be equally common among men and women. The two major factors leading to the rise in the consumption of antidepressants are the course of the treatment lasting longer than it used to be, and the antidepressants that are currently being prescribed are not only for severe depression, but also for mild depression, anxiety, social phobia, and more. The increasing prevalence of disorders and increasing rate of consumption of antidepressants are expected to drive the market studied during the forecast period.
Competitive Landscape
The market studied comprises of a combination of multinational and domestic players. The entry barriers are comparatively less, and most of the drugs are available over the counter. The companies are trying to expand their geographical presence by partnerships or acquisitions. Some of the key players in the market are Allergan PLC, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck AS, Johnson & Johnson, and Pfizer Inc.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Cases of Depression
4.2.2 Increasing Awareness about Depression
4.2.3 Emergence of Novel Biologics
4.3 Market Restraints
4.3.1 Preference of Non-pharmacological Therapies over Pharmacological Therapies
4.3.2 Side-effects and Patent Expiry of Antidepressant Drugs
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Selective Serotonin Reuptake Inhibitor (SSRI)
5.1.2 Serotonin-norepinephrine Reuptake Inhibitor (SNRI)
5.1.3 Tricyclic Antidepressant (TCA)
5.1.4 Monoamine Oxidase Inhibitor (MAOI)
5.1.5 Other Products
5.2 By Depressive Disorder
5.2.1 Major Depressive Disorder
5.2.2 Obsessive-compulsive Disorder (OCD)
5.2.3 Generalized Anxiety Disorder (GAD)
5.2.4 Panic Disorder (PD)
5.2.5 Other Depressive Disorders
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan PLC
6.1.2 AstraZeneca
6.1.3 Eli Lilly and Company
6.1.4 GlaxoSmithKline PLC
6.1.5 H. Lundbeck AS
6.1.6 Johnson & Johnson
6.1.7 Merck & Co. Inc.
6.1.8 Pfizer Inc.
6.1.9 Sanofi
6.1.10 Sun Pharmaceuticals Pvt Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Selective Serotonin Reuptake Inhibitor (SSRI)
Serotonin-norepinephrine Reuptake Inhibitor (SNRI)
Tricyclic Antidepressant (TCA)
Monoamine Oxidase Inhibitor (MAOI)
Other Products
By Depressive Disorder
Major Depressive Disorder
Obsessive-compulsive Disorder (OCD)
Generalized Anxiety Disorder (GAD)
Panic Disorder (PD)
Other Depressive Disorders
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Small Molecule Drug Discovery Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The global small molecule drug discovery market was valued at USD 29,363.85 million in 2018, and is estimated to be valued at USD 46,882.22 million in 2024, witnessing a CAGR of 8.11%. The increasing applications of small molecule drugs for the treatment of chronic diseases are leading to the increased demand for these drugs in the market. Moreover, due to the aforementioned factors, small molecule drugs dominate the biologics in the current healthcare market. The preference of small molecules, along with the increasing disease complications and technological advancements, has led major players to increase their R&D expenditure, which is further acting as the major growth driver for the global small molecule drug discovery market.
The global small molecule drug discovery market is subject to impacts from political situations. The policy implemented by the government has the capability to either amplify or diminish the market.
Scope of the Report
This report estimates the global small molecule drug discovery market. It includes the detailed analysis of small molecules that are in the drug discovery phase only and does not include any other products.
Key Market Trends
Lead Optimization is Expected to hold its Highest Market Share in the Process/Phase Segment
In the process/phase segment of the market, lead optimization is believed to have the largest market size and is expected to witness a CAGR of 7.93% during the forecast period.
The process of lead optimization is achieved by modifying the selected small molecule, in order to improve efficacy and therapeutic value. Once the pharmacophore, which consists of relevant groups on a molecule that interact with a receptor and are responsible for the biological activity, is identified, it is subjected to functional group modification. Various changes are made to the initial compound and the therapeutic index is measured.
Rapid usage of in-vitro experiments, accompanied with computation procedures in early drug discovery for selection of compounds with more promising ADME, i.e., absorption, distribution, metabolism, and excretion, and toxicological profiles, is expected to drive the market studied.
The rise in cancer and other neglected diseases is encouraging investments in lead optimization for enhanced therapeutic value, in order to provide patients with efficient and targeted therapies.
North America Dominates the Market and is Expected to follow the Same Trend in the Forecast Period
North America currently dominates the market for small molecule drug discovery and is expected to continue its stronghold for a few more years. According to FDA, in 2016, the Center for Drug Evaluation and Research (CDER) approved 22 novel drugs, either as new molecular entities (NMEs) under New Drug Applications (NDAs) or as new therapeutic biologics under Biologics License Applications (BLAs). Overall, 31,468 patients participated in these trials. This shows that the United States is focusing on R&D activities to meet the increasing demands of its citizens for better and effective drugs.
The rising focus on the R&D in the country is expected to propel the market growth in the future.
Competitive Landscape
The small molecule drug discovery market is moderately competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new ingredients with fewer prices. Companies, like Pfizer Inc., Bristol-Myers Squibb Company, Merck & Co., Boehringer Ingelheim GmbH, and GlaxoSmithKline, hold the substantial share in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Demand for Small Molecule Drugs
4.2.2 Dominance of Small Molecules in the Market
4.2.3 Increasing Number of Contract Organizations for R&D
4.2.4 Small Molecules in Treatment of Chronic Diseases
4.2.5 High R&D Expenditure in Small Molecule Drugs
4.3 Market Restraints
4.3.1 High Drug Development Cost
4.3.2 Strict Regulations
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Therapeutic Area
5.1.1 Oncology
5.1.2 Central Nervous System
5.1.3 Cardiovascular
5.1.4 Respiratory
5.1.5 Metabolic Disorders
5.1.6 Gastrointestinal
5.1.7 Orthopedics
5.1.8 Anti-infective
5.1.9 Dermatology
5.1.10 Immunology
5.1.11 Other Therapeutic Areas
5.2 By Process/Phase
5.2.1 Target Id/Validation
5.2.2 Hit Generation and Selection
5.2.3 Lead Identification
5.2.4 Lead Optimization
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Pfizer Inc.
6.1.2 Bristol-Myers Squibb Company
6.1.3 Merck & Co.
6.1.4 Boehringer Ingelheim GmbH
6.1.5 GlaxoSmithKline PLC
6.1.6 AstraZeneca
6.1.7 Johnson & Johnson
6.1.8 Gilead Sciences Inc.
6.1.9 Teva Pharmaceuticals
6.1.10 Teva Pharmaceutical Industries Ltd
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Therapeutic Area
Oncology
Central Nervous System
Cardiovascular
Respiratory
Metabolic Disorders
Gastrointestinal
Orthopedics
Anti-infective
Dermatology
Immunology
Other Therapeutic Areas
By Process/Phase
Target Id/Validation
Hit Generation and Selection
Lead Identification
Lead Optimization
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Medical Imaging Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The major factors augmenting the growth of the medical imaging market include the rise in the prevalence of chronic diseases, increased adoption of advanced technologies in medical imaging, and rise in the geriatric population.
The burden of chronic diseases is on the rise globally, and medical imaging procedures play a crucial role in the accurate diagnosis of chronic diseases. The increase in the aging population and changes in societal behavior are contributing to a steady increase in these common and costly long-term health problems. Most of the deaths by chronic diseases are attributable to cardiovascular diseases, obesity, and diabetes. According to WHO, the global burden of chronic diseases is expected to reach 57% by 2020. The most affected would be the emerging markets, as the population growth is anticipated to be most significant in developing areas.
New models for therapy and diagnoses are being developed, which provide precise results, help in early detection of diseases, and help minimize the cost of treating these diseases. With the increasing disposable income, people are becoming capable enough to have access to imaging procedures for early detection of diseases.
Furthermore, the medical imaging field has advanced at a great pace, stimulated by advances in digital and communication technologies. New imaging techniques that reveal greater anatomical details are available in most of the diagnostic labs and hospitals. The aim is to improve access and precision, decrease cost, and make the impact of radiation less harmful. The trend is shifting from fixed to portable equipment. For example, until recently, size and electricity requirement have hindered the proper use of ultrasound. Today, smaller ultrasound equipment can provide color-flow Doppler imaging, relying on battery power solely.
Scope of the Report
As per the scope of the report, the medical imaging market covers a wide array of medical devices used for diagnostic purposes. It has a vast range of applications in a variety of oncological, orthopedic, gastro- and gynecological fields. With advanced healthcare facilities and growing healthcare expenditure, North America is expected to dominate this market, followed by the European region. The market is segmented by product type, application, and geography.
Key Market Trends
Oncology Segment under Application is expected to Account for Largest Market Share during the Forecast Period
Oncology deals with diagnosis and treatment of tumors and cancers, which is one the leading causes of morbidity and mortality. Among both sexes, lung, breast, and colorectal cancers are among the most common cancers in the world with lung cancer alone contributing to more than 13% of the total cases diagnosed.
According to WHO, cancer was responsible for 8.8 million deaths in 2015, including nearly 1 in 6 deaths globally. In addition, one-third of deaths are due to high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use (includes approximately 22% of cancer deaths), and alcohol use. Additionally, there are several minor side effects, such as nausea, headaches, dry mouth, diarrhea, allergic reaction, and others, as well as some major side effects, such as kidney disease, dementia, and others associated with its use, which can affect the adoption rate, and hence can be a restraining factor in the market.
Medical imaging plays a vital role in interventional oncology (with rising opportunities to diagnose and treat in a targeted and minimally or non-invasive manner) as well as in chemo and radiation therapy. Tools, such as CT, are the highly beneficial and preferred method of imaging for many conditions, including trauma patients. Comparatively, PET is mostly preferred as compared to SPECT, and there are hybrid medical devices also available such as PET/CT or PET/MRI.
North America accounted for the Largest Share in the Global Market
North America is found to hold a major share of the medical imaging market and is expected to show a similar trend over the forecast period, without significant fluctuations. The United States contributes to the major share in the medical imaging market, which can be attributed to the increasing technological advances, higher affordability rates from the population, and the number of diagnostic procedures increasing on a yearly basis. According to OECD, till 2007, the number of MRI units being available per one million of the population was 25.9. The volume rose to approximately 39 by 2015, reported as of 2017, including 20.3 in ambulatory services and 18.7 in hospitals. MRI diagnostic is a growing field, both in terms of the number of the installed scanner and in the number of scans being performed. Based on the data by OECD, the United States is one of the leaders, second only to Japan, both in terms of availability and utilization.
Hence, with the presence of well-established healthcare facilities, increasing demand for advanced healthcare systems among the aging population, and increasing prevalence of chronic diseases, the market is expected to grow in the forecast period.
Competitive Landscape
The market studied is consolidated owing to the presence of a few major players in the market. The market players are focusing on R&D to develop the technologically advanced products in order to reduce the cost and side effects associated with the products. The barriers for the new entrants are high in this industry, and hence few major market players hold the maximum market share.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Chronic Diseases
4.2.2 Increased Adoption of Advanced Technologies in Medical Imaging
4.2.3 Increase in the Geriatric Population
4.3 Market Restraints
4.3.1 Expensive Procedures and Equipment
4.3.2 Side Effects of Diagnostic Imaging
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 X-Ray Equipment
5.1.1.1 Stationary
5.1.1.2 Portable
5.1.2 Fluoroscopy
5.1.2.1 Fixed Fluoroscope
5.1.2.2 Mobile Fluoroscope
5.1.3 MRI
5.1.3.1 Closed Systems
5.1.3.2 Open Systems
5.1.4 Ultrasound
5.1.5 Computed Tomography
5.1.6 Other Imaging Modalities
5.2 By Application
5.2.1 Cardiology
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Orthopedics
5.2.5 Gastroenterology
5.2.6 Gynecology
5.2.7 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 Carestream Health Inc.
6.1.3 Esaote SpA
6.1.4 FUJIFILM Holdings Corporation
6.1.5 GE Healthcare
6.1.6 Hitachi Medical Systems
6.1.7 Hologic Corporation
6.1.8 Koninklijke Philips N.V.,
6.1.9 Shimadzu Medical
6.1.10 Siemens Healthineers
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product Type
X-Ray Equipment
Stationary
Portable
Fluoroscopy
Fixed Fluoroscope
Mobile Fluoroscope
MRI
Closed Systems
Open Systems
Ultrasound
Computed Tomography
Other Imaging Modalities
By Application
Cardiology
Oncology
Neurology
Orthopedics
Gastroenterology
Gynecology
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Nebulizer Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The global nebulizer market was valued at USD 862.75 million in 2018, and it is estimated to value at USD 1,255.33 million by 2024, while witnessing a CAGR of 6.45% during the forecast period, 2019-2024. There are certain factors that are driving the market growth, including rising incidences of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population base.
Nebulizers are respiratory drug delivery devices that transform liquid medications into aerosols (liquid particles in a gas). The drug is converted into a mist that can be directly delivered to the patient’s lungs. The rising incidences of chronic respiratory diseases and rapid technological advances are among the key factors driving the usage of nebulizers.
The adoption is also increasing, due to the demand for new technologies with higher quality, smaller size, lighter weight, and ease of accessibility, by the patients.
Thus, the increasing demand for home healthcare devices is driving the growth of the market studied.
Scope of the Report
Nebulizer is a medical device that converts the drug into mist and delivers it directly to the lungs. The technique of nebulization is commonly used for the treatment of respiratory diseases, including asthma, cystic fibrosis, and COPD. There are various devices that can be used for nebulization. Some of the devices are rechargeable, and electrically powered ones are the most widely used.
Key Market Trends
Mesh Nebulizer Segment is Expected to Hold the Largest Market Share
The mesh nebulizer segment of the global nebulizer market is expected to witness a high CAGR of 7.60% over the forecast period.
Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments. Thus it was estimated that mesh nebulizers will be increasingly adopted in the coming future. This is due to the portability, convenience, and speed of treatment, owing to their low residual volumes and accurate lung delivery. Thus, technological advancements in mesh nebulizers, with the development of an innovative solution, are likely to further drive the growth of the market in the future.
There has also been a rising adoption of portable nebulizers by patients, which is contributing toward the market growth. Portable nebulizers are expected to witness robust growth, owing to the ease and convenience of use, technological advancement in devices, and launch of several new products in recent years.
North America Dominates the Market and is Expected to do so over the Forecast Period
The North American nebulizer market is growing, due to the continuous innovations in technology. As the population in the region follows a fast-moving lifestyle, patients are looking for more portable nebulizer devices that can be transferred easily in time of need for patients suffering from asthma and other airway diseases.
In addition, healthcare cost containment issues, post economic crisis in the United States, have required the government to introduce new strategies to reduce patient stays in hospitals. This provided impetus to homecare services, which in turn, created a favorable environment for the growth of the nebulizer market.
Competitive Landscape
The global nebulizer market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, various strategies, such as mergers and acquisitions, product approvals, and agreements, are being adopted by these key market players to increase the outreach of their products and strengthen their product portfolios. The major players are Agilent Technologies Becton, Dickinson and Company, and GF Health Products Inc.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidences of Chronic Respiratory Diseases
4.2.2 Increasing Demand for Home Healthcare Devices
4.2.3 Rising Geriatric Population Base
4.3 Market Restraints
4.3.1 Drug Loss during Drug Delivery
4.4 Industry Attractiveness Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Pneumatic Nebulizer
5.1.2 Ultrasonic Nebulizer
5.1.3 Mesh Nebulizer
5.2 By Portability
5.2.1 Tabletop Nebulizer
5.2.2 Portable Nebulizer
5.3 Sales Channel
5.3.1 Direct Purchase
5.3.2 Online Purchase
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies
6.1.2 Becton Dickinson and Company
6.1.3 Briggs Healthcare
6.1.4 Drive DeVilbiss Healthcare
6.1.5 GF Health Products Inc.
6.1.6 Invacare Corporation
6.1.7 Koninklijke Philips NV
6.1.8 Medline Industries Inc.
6.1.9 Omron Corporation
6.1.10 PARI Pharma
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Type
Pneumatic Nebulizer
Ultrasonic Nebulizer
Mesh Nebulizer
By Portability
Tabletop Nebulizer
Portable Nebulizer
Sales Channel
Direct Purchase
Online Purchase
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
US Diagnostic Imaging Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 72 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 72 pages
- Published: 07-06-2019
Market Overview
The major factors for the growth of the US diagnostic imaging market include the technological advancement in imaging modalities, growing awareness regarding preventive care, the rising number of diagnostic imaging centers, increasing prevalence of chronic diseases, and increasing geriatric population.
The United States is expected to experience an accelerated rate of aging population, as compared to other developed countries. The growth in aging population leads to an increase in the demand for imaging services, since the elderly population is more prone to chronic diseases. According to the National Institutes of Health (NIH) Data, patients aged 65 and above undergo diagnostic imaging two or more times more than the younger population. The number of times women undergo diagnostic imaging is expected to be slightly higher than that of men. The proportion of the older population in the United States, with favorable insurance coverage policies, is likely to drive the market. According to the estimates of the American Cancer Society, in 2018, there were 1,735,350 new cancer cases diagnosed and 609,640 cancer deaths in the United States. The rising number of cases of cancer are creating tremendous opportunities for market players.
Scope of the Report
As per the scope of the report, the US diagnostic imaging market covers diagnostic imaging used to take images of the internal structure of the human body using electromagnetic radiation, the for accurate diagnosis of the patient. It has vast applications in a variety of oncological, orthopedic, gastro- and gynecological fields. The market is segmented by product, application, end user, and geography.
Key Market Trends
Magnetic Resonance Imaging (MRI) Segment by Product is Expected to Account for the Largest Market Share during the Forecast Period
The MRI segment is set to dominate the US diagnostic imaging market. The factors attributing to the high growth of MRI in the country are growing technological advancements in MRI modality and widening the application of MRI in the medical field. As per the estimates of the Organisation for Economic Co-operation and Development (OECD), in 2017, in the United States, there were a total number of 111 MRI exams per 1000 inhabitants. In order to increase awareness among physicians, some of the market players are providing training courses. For instance, Bruker BioSpin is one of the companies that is offering training courses for MRI customers in Europe and the United States. Under this course, it covers a wide range of applications from introductory classes to advanced operator courses. Thus, owing to the rising prevalence of chronic diseases and technological advancements, the market is expected to witness a healthy CAGR over the forecast period.
Competitive Landscape
The US diagnostic imaging market is consolidated, owing to the presence of few major players. The market players are focusing on R&D to develop technologically advanced products, in order to reduce the cost and side effects associated with the products. The barriers for the new entrants are high in this industry, and hence, few major market players hold the maximum market share.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancement in Imaging Modalities
4.2.2 Growing Awareness Regarding Preventive Care
4.2.3 Rising Number of Diagnostic Imaging Centers
4.2.4 Increasing Prevalence of Chronic Diseases and Rising Geriatric Population
4.3 Market Restraints
4.3.1 Dearth of Radiologists
4.3.2 Reduction in Reimbursement Rate
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 X-ray Radiology
5.1.2 Ultrasound
5.1.3 Magnetic Resonance Imaging (MRI)
5.1.4 Mammography
5.1.5 Computed Tomography
5.1.6 Nuclear Medicine
5.1.6.1 Positron Emission Tomography (PET)
5.1.6.2 Single-photon Emission Computerized Tomography (SPECT)
5.2 By Application
5.2.1 Cardiology
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Orthopedic
5.2.5 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Diagnostic Centers
5.3.3 Other End Users
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 Carestream Health Inc.
6.1.3 Esaote SpA
6.1.4 FUJIFILM Holdings Corporation
6.1.5 GE Healthcare
6.1.6 Hitachi Medical Systems
6.1.7 Hologic Corporation
6.1.8 Koninklijke Philips NV
6.1.9 Shimadzu Medical
6.1.10 Siemens Medical Solutions USA, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
X-ray Radiology
Ultrasound
Magnetic Resonance Imaging (MRI)
Mammography
Computed Tomography
Nuclear Medicine
Positron Emission Tomography (PET)
Single-photon Emission Computerized Tomography (SPECT)
By Application
Cardiology
Oncology
Neurology
Orthopedic
Other Applications
By End User
Hospitals
Diagnostic Centers
Other End Users